Granules India Limited Discontinued
FDA Approved Drugs

Granules India Limited Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 21
  • Latest Approval Date Sep 29, 2023
  • Data Source FDA
  • First Approval Date Jan 27, 2009
All
83
View
Unclassified
2
View
Discontinued
21
View
OTC
12
View
RX
48
View
Company Overview

Company

Granules India Limited Discontinued

Country

India

Website

Visit Website

Email

mail@granulesindia.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Granules India Limited Discontinued

2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad- 500 081 (TG)

India

granulesindia.com/ mail@granulesindia.com View on Map
FDA Approved Drug Records ( 21 records )
2022
22 Aug
Discontinued Application: 216082

Drug Name

GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

600MG;60MG

Approval Date

2022-08-22

216082 / 1

Active Ingredient

GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE

Application Number

216082

Product Number

1

Dosage Form

-

Strength

600MG;60MG

Approval Date

2022-08-22

Regulatory Status

Discontinued

2022
22 Aug
Discontinued Application: 216082

Drug Name

GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

1.2GM;120MG

Approval Date

2022-08-22

216082 / 2

Active Ingredient

GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE

Application Number

216082

Product Number

2

Dosage Form

-

Strength

1.2GM;120MG

Approval Date

2022-08-22

Regulatory Status

Discontinued

2009
27 Jan
Discontinued Application: 78982

Drug Name

LAMOTRIGINE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2009-01-27

78982 / 1

Active Ingredient

LAMOTRIGINE

Application Number

78982

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2009-01-27

Regulatory Status

Discontinued

2009
27 Jan
Discontinued Application: 78982

Drug Name

LAMOTRIGINE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2009-01-27

78982 / 2

Active Ingredient

LAMOTRIGINE

Application Number

78982

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2009-01-27

Regulatory Status

Discontinued

2009
27 Jan
Discontinued Application: 78982

Drug Name

LAMOTRIGINE

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

2009-01-27

78982 / 3

Active Ingredient

LAMOTRIGINE

Application Number

78982

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

2009-01-27

Regulatory Status

Discontinued

2009
27 Jan
Discontinued Application: 78982

Drug Name

LAMOTRIGINE

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2009-01-27

78982 / 4

Active Ingredient

LAMOTRIGINE

Application Number

78982

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2009-01-27

Regulatory Status

Discontinued

2023
13 Jun
Discontinued Application: 217878

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2023-06-13

217878 / 1

Active Ingredient

LEVETIRACETAM

Application Number

217878

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2023-06-13

Regulatory Status

Discontinued

2023
13 Jun
Discontinued Application: 217878

Drug Name

LEVETIRACETAM

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2023-06-13

217878 / 2

Active Ingredient

LEVETIRACETAM

Application Number

217878

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2023-06-13

Regulatory Status

Discontinued

2023
13 Jun
Discontinued Application: 217878

Drug Name

LEVETIRACETAM

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2023-06-13

217878 / 3

Active Ingredient

LEVETIRACETAM

Application Number

217878

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2023-06-13

Regulatory Status

Discontinued

2023
13 Jun
Discontinued Application: 217878

Drug Name

LEVETIRACETAM

Product Number

4

Dosage Form

-

Strength

1GM

Approval Date

2023-06-13

217878 / 4

Active Ingredient

LEVETIRACETAM

Application Number

217878

Product Number

4

Dosage Form

-

Strength

1GM

Approval Date

2023-06-13

Regulatory Status

Discontinued

2013
26 Mar
Discontinued Application: 90486

Drug Name

LEVOCETIRIZINE DIHYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2013-03-26

90486 / 1

Active Ingredient

LEVOCETIRIZINE DIHYDROCHLORIDE

Application Number

90486

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2013-03-26

Regulatory Status

Discontinued

2022
29 Aug
Discontinued Application: 215981

Drug Name

LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE

Product Number

1

Dosage Form

-

Strength

2MG;125MG

Approval Date

2022-08-29

215981 / 1

Active Ingredient

LOPERAMIDE HYDROCHLORIDE; SIMETHICONE

Application Number

215981

Product Number

1

Dosage Form

-

Strength

2MG;125MG

Approval Date

2022-08-29

Regulatory Status

Discontinued

2023
29 Sep
Discontinued Application: 218015

Drug Name

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG;50MG

Approval Date

2023-09-29

218015 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Application Number

218015

Product Number

1

Dosage Form

-

Strength

12.5MG;50MG

Approval Date

2023-09-29

Regulatory Status

Discontinued

2023
29 Sep
Discontinued Application: 218015

Drug Name

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

12.5MG;100MG

Approval Date

2023-09-29

218015 / 2

Active Ingredient

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Application Number

218015

Product Number

2

Dosage Form

-

Strength

12.5MG;100MG

Approval Date

2023-09-29

Regulatory Status

Discontinued

2023
29 Sep
Discontinued Application: 218015

Drug Name

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

25MG;100MG

Approval Date

2023-09-29

218015 / 3

Active Ingredient

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Application Number

218015

Product Number

3

Dosage Form

-

Strength

25MG;100MG

Approval Date

2023-09-29

Regulatory Status

Discontinued

2023
07 Aug
Discontinued Application: 216509

Drug Name

METOPROLOL SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG TARTRATE

Approval Date

2023-08-07

216509 / 1

Active Ingredient

METOPROLOL SUCCINATE

Application Number

216509

Product Number

1

Dosage Form

-

Strength

EQ 25MG TARTRATE

Approval Date

2023-08-07

Regulatory Status

Discontinued

2023
07 Aug
Discontinued Application: 216509

Drug Name

METOPROLOL SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 50MG TARTRATE

Approval Date

2023-08-07

216509 / 2

Active Ingredient

METOPROLOL SUCCINATE

Application Number

216509

Product Number

2

Dosage Form

-

Strength

EQ 50MG TARTRATE

Approval Date

2023-08-07

Regulatory Status

Discontinued

2023
07 Aug
Discontinued Application: 216509

Drug Name

METOPROLOL SUCCINATE

Product Number

3

Dosage Form

-

Strength

EQ 100MG TARTRATE

Approval Date

2023-08-07

216509 / 3

Active Ingredient

METOPROLOL SUCCINATE

Application Number

216509

Product Number

3

Dosage Form

-

Strength

EQ 100MG TARTRATE

Approval Date

2023-08-07

Regulatory Status

Discontinued

2023
07 Aug
Discontinued Application: 216509

Drug Name

METOPROLOL SUCCINATE

Product Number

4

Dosage Form

-

Strength

EQ 200MG TARTRATE

Approval Date

2023-08-07

216509 / 4

Active Ingredient

METOPROLOL SUCCINATE

Application Number

216509

Product Number

4

Dosage Form

-

Strength

EQ 200MG TARTRATE

Approval Date

2023-08-07

Regulatory Status

Discontinued

2018
20 Aug
Discontinued Application: 210243

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-08-20

210243 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

210243

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-08-20

Regulatory Status

Discontinued

2018
20 Aug
Discontinued Application: 210243

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-08-20

210243 / 2

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

210243

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-08-20

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    20 View
  • EDQM CEP
    31 View
  • KDMF
    0 View
  • Japan DMF
    2 View
  • Eudra GMP
    0 View
  • NDC Database
    95 View
  • FDA Approved Drugs Database
    83 View
Drug Status Breakdown
21 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE

Application Number

216082

Product Number

1

Active Ingredient

GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE

Dosage Form

-

Strength

600MG;60MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit